2019 Drug Launches: New Specialty And Rare Disease Blockbusters Take Shape

 
• By Jessica Merrill

Novartis' Zolgensma and Pfizer's Vyndaqel were two of the early commercial standouts in 2019, on a likely blockbuster trajectory, while AbbVie's Skyrizi is poised to be fierce competitor in psoriasis.

Rocket takes off in the starry sky. Spaceship begins the mission. Space shuttle taking off on a Planet Mars.
Scrip looks back at the commercial winners that launched in 2019

More from New Products

More from Scrip